stars 1 stars 2 stars 3

KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and developed a large portfolio of technologies for manufacturing generic versions of complex drugs, high quality biosimilars and biologics. Augmented by our global partnerships, KinBio is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoperosis. Our state of the art cGMP manufacturing plants consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs) through FDA approved fully fledged sterile drug products plants.

KinBio Questions

Gila Cohen is the Director of Finance of KinBio.

8 people are employed at KinBio.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users